Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors

American Journal of Surgical Pathology

Volumn 22, Issue 9, 1998, Pages 1125-1131

  Hanby, Andrew M ^a   McKee, Phillip ^b   Jeffrey, Margaret ^c   Grayson, Wayne ^d   Dublin, Edwin ^a   Poulsom, Richard ^e   Maguire, Brigid ^f  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Breast; Estrogen receptor; Mucinous carcinoma; Progesterone receptor; Skin; Tamoxifen; TFF1; TFF2; TFF3

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; MUCIN; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY; TREFOIL PEPTIDE;

ADULT; AGED; ARGYROPHILIA; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MUCINOUS CARCINOMA; RNA PROBE; SKIN BIOPSY; SKIN CARCINOMA;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; VULVAR NEOPLASMS;

EID: 0031711815     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199809000-00012     Document Type: Article

References (36)

1. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD. Immunohistochemical determination of estrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996;74:1445-51.
2. Carson HJ, Gattuso P, Raslan WF, Reddy V. Mucinous carcinoma of the eyelid - an immunohistochemical study. Am J Dermatopathol 1995;17:494-8.
3. Capella C, Eusebi V, Mann B, Azzopardi JG. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980;4: 613-30.
4. Cornil V. Cited by Smith CCK. Metastasizing carcinoma of sweat glands. Br J Surg 1955;43:80-4.
5. Elia G, Chinery R, Hanby AM, Poulsom R, Wright NA. The production and characterization of a new monoclonal antibody to the trefoil peptide HSP. Histochem J 1994;26:644-7.
6. Elston CW, Ellis O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19:403-10.
7. Fentiman IS, Millis RR, Smith P, Ellul JPM, Lampejo O. Mucoid breast carcinomas: histology and prognosis. Brit J Cancer 1997; 75:1061-5.
8. Fisher CJ, Millis RR. A mucocele-like tumor of the breast associated with both atypical ductal hyperplasia and mucoid carcinoma. Histopathology 1992;23:69-71.
9. Gmachl M, Berger H, Thalhammer J, Kreil G. Dermal glands of Xenopus laevis contain a polypeptid with a highly repetitive amino acid sequence. FEBS Lett 1990;260:145-8.
10. Hanby AM and Wright NA. The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol 1993;171:3-4.
11. Happerfield LC, Echezarreta G, Gillett CG Hanby AM, Barnes DM, Bobrow LG. Assessment of estrogen and progesterone receptor antibodies in formalin-fixed routinely processed paraffin-wax embedded tissue. J Cell Path 1996;1:170-8.
12. Henry JA, Piggott NH, Mallick UK, Nicholson-S, Farndon JR, Westley BR, May FE. pNR-2/PS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991;63:615-22.
13. Horwitz KB, McGuire WL, Pearson OH. Predicting respose to endocrine therapy in human breast cancer: a hypothesis. Science 1975;189:726-7.
14. Jakowlew SB, Breathnach R, Jetsch JM, Masiakowski P, Chambon P. Sequence of the PS2 mRNA induced by estrogen in the breast cancer cell line. MCF-7. Nucleic Acid Res 1984;12:2861-78.
15. Kiang DT, Frenning DH, Goldman AL, Ascensao VF, Kennedy BJ. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 1978;299:1330-4.
16. Lloveras B, Googe P, Goldberg D, Bhan A. Estrogen receptor in skin appendage tumors and extramammary Paget's disease. Lab Invest 1990;62:59A.
17. Mansour AM, Hidayat AA. Metastatic eyelid disease. Opthalmology 1987;94:667-70.
18. Melamed MR, Robbins GF, Foote Jr FW. Prognostic significance of gelatinous mammary carcinoma. Cancer 1961;14:699-704.
19. Millis RR, Girling AC, Hanby AM. The "breast." In: Sternberg SS, ed. Diagnostic Surgical Pathology. 2nd ed. New York: Raven Press; 1993:361.
20. Nahass GT, Otrakji CJ, Gould E. Mucinous breast carcinoma: single cutaneous metastasis. J Dermatol Surg Oncol 1993;19:878-80.
21. Nunez AM, Berry M, Imler JL, Chambon P. The 5′ flanking region of the PS2 gene contains a complex enhancer region responsive to estrogen, EGF, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 1989;8:823-9.
22. Pallud C, Le Doussal V, Pichon MF, Prud'homme JF, Hacene K, Milgrom E. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumors. Histopathology 1993;23:249-56.
23. Poulsom R. Trefoil peptides. Baillieres Clinical Gastroenterology 1996;10:113-34.
24. Poulsom R, Hanby AM, Lalani E-N, Hauser F, Hoffman W, Stamp GWH. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic breast epithelium. J Pathol 1997; 183:30-8.
25. Rasmussen BB, Rose C, Thorpe SM, Andersen KW, Hou-Jensen K. Argyrophillic cells in 202 human mucinous breast carcinomas. Am J Clin Pathol 1985;84:737-40.
26. Roa KV, Tikku I, Kapur MB, Chopra P. Invasive primary mucinous carcinoma of the skin. Int Surg 1978;63:168-70.
27. Rodrigues MM, Font RL, Shannon GM. Metastatic mucus-secreting mammary carcinoma in the eyelid. Brit J Opthalmol 1977;58:577-81.
28. Rio MC, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988;241:705-7.
29. Rosen PP. Mucocele-like tumors of the breast. Am J Surg Pathol 1986;10:464-9.
30. Rosen PP, Wang Ty. Colloid carcinoma of the breast: analysis of 64 patients with long-term follow up. Am J Clin Pathol 1980;73:304.
31. Snow SN, Reizner GT. Mucinous eccrine carcinoma of the eyelid. Cancer 1992;70:2099-104.
32. Soubeyran I, Wafflart J, Benichon F, et al. Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases. Breast Cancer Res Treat 1995;34:119-28.
33. Swanson PE, Mazoujian G, Mills SE, Campbell RJ, Wick MR. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 1991;15:835-41.
34. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Keiding N. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer res 1987;47:6126-33.
35. Wright NA, Hoffman W, Otto WR, Rio MC, Thim L. Rolling in the clover - trefoil factor (TFF) domain peptides, cell-migration and cancers. FEBS Lett 1997;408:121-3.
36. Yeung K, Stinson JC. Mucinous (adenocystic) carcinoma of the sweat glands with widespread metastasis. Cancer 1977;39:3556-62.